| Literature DB >> 1902290 |
Abstract
Aztreonam is the first monobactam available for use in this country. A parenteral antibiotic, its antibacterial spectrum is limited to gram-negative aerobic pathogens. The drug's pharmacologic, pharmacokinetic, and toxicologic properties are reviewed. Based on early experience in pediatric patients, certain recommendations can be made for the use of aztreonam.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1902290
Source DB: PubMed Journal: Pharmacotherapy ISSN： 0277-0008 Impact factor: 4.705